Table 1 Comparison of IVI scores by sociodemographic and clinical characteristics (N = 2652).

From: Different impact of early and late stages irreversible eye diseases on vision-specific quality of life domains

Baseline characteristic

n (%)

Emotional

Mobility

Reading

Mean ± SD

% reduction

Mean ± SD

% reduction

Mean ± SD

% reduction

Age, year

 

40–49

640 (24.1)

5.34 ± 1.18

0.0

5.55 ± 0.70

0.0

5.23 ± 0.98

0.0

50–59

1209 (45.6)

5.49 ± 1.22

2.8

5.55 ± 0.75

0.0

5.41 ± 0.84

3.4

60–69

536 (20.2)

5.54 ± 1.07

3.9

5.42 ± 0.97

− 2.4

5.28 ± 1.02

1.0

70+ 

267 (10.1)

5.38 ± 1.33

0.8

4.94 ± 1.56

− 11.0

4.77 ± 1.54

− 8.8

  

P = 0.011

 

P < 0.001

 

P < 0.001

 

Gender

 

Male

1283 (48.4)

5.49 ± 1.18

0.0

5.50 ± 0.85

0.0

5.29 ± 0.99

0.0

Female

1369 (51.6)

5.42 ± 1.21

− 1.3

5.43 ± 0.97

− 1.2

5.26 ± 1.04

− 0.6

  

P = 0.135

 

P = 0.063

 

P = 0.419

 

Race

Malay

491 (18.5)

5.69 ± 0.99

0.0

5.40 ± 1.09

0.0

5.25 ± 1.09

0.0

Indian

546 (20.6)

5.71 ± 1.15

0.3

5.58 ± 0.77

3.4

5.48 ± 0.81

4.2

Chinese

1615 (60.9)

5.29 ± 1.24

− 7.0

5.45 ± 0.90

0.9

5.21 ± 1.04

− 0.8

  

P < 0.001

 

P = 0.002

 

P < 0.001

 

Educational level

 

Secondary or higher

1446 (54.5)

5.44 ± 1.19

REF

5.54 ± 0.77

REF

5.33 ± 0.93

REF

Primary or below

1206 (45.5)

5.46 ± 1.20

0.4

5.38 ± 1.06

− 3.0

5.21 ± 1.10

− 2.4

  

P = 0.620

 

P < 0.001

 

P = 0.001

 

Monthly income

 

 ≥ S$2000

1024 (38.6)

5.49 ± 1.09

REF

5.59 ± 0.63

REF

5.38 ± 0.85

REF

 < S$2000

1628 (61.4)

5.43 ± 1.26

− 1.2

5.38 ± 1.05

− 3.7

5.21 ± 1.10

− 3.1

  

P = 0.184

 

P < 0.001

 

P < 0.001

 

Housing

 

5 room house or private

1086 (41.0)

5.45 ± 1.11

REF

5.51 ± 0.82

REF

5.30 ± 0.99

REF

3–4 room or less

1566 (59.0)

5.45 ± 1.25

− 0.1

5.43 ± 0.98

− 1.4

5.26 ± 1.03

− 0.8

  

P = 0.901

 

P = 0.034

 

P = 0.281

 

Lifestyle factors

 

BMI category

 

 Underweight

98 (3.7)

5.37 ± 1.20

0.0

5.57 ± 0.74

0.0

5.21 ± 1.05

0.0

 Normal

1370 (51.7)

5.37 ± 1.28

0.1

5.44 ± 0.95

− 2.2

5.24 ± 1.05

0.4

 Overweight

886 (33.4)

5.52 ± 1.12

2.9

5.47 ± 0.92

− 1.9

5.31 ± 0.99

1.9

 Obese

298 (11.2)

5.64 ± 0.94

5.2

5.53 ± 0.79

− 0.8

5.37 ± 0.90

3.0

  

P = 0.001

 

P = 0.346

 

P = 0.099

 

Smoking status

 

 Never

1962 (74.0)

5.45 ± 1.17

0.0

5.48 ± 0.90

0.0

5.30 ± 0.99

0.0

 Current

371 (14.0)

5.43 ± 1.30

− 0.4

5.52 ± 0.72

0.8

5.24 ± 1.02

− 1.2

 Past

319 (12.0)

5.47 ± 1.22

0.4

5.33 ± 1.14

− 2.7

5.17 ± 1.16

− 2.5

  

P = 0.888

 

P = 0.013

 

P = 0.075

 

Alcohol use

 

 No

2425 (91.4)

5.47 ± 1.18

REF

5.46 ± 0.93

REF

5.27 ± 1.02

REF

 Yes

227 (8.6)

5.28 ± 1.31

− 3.4

5.53 ± 0.72

1.4

5.34 ± 0.91

1.4

  

P = 0.024

 

P = 0.248

 

P = 0.291

 

Comorbid conditions

Diabetes

 No

2080 (78.4)

5.44 ± 1.18

REF

5.48 ± 0.87

REF

5.27 ± 1.01

REF

 Yes

572 (21.6)

5.49 ± 1.26

0.8

5.41 ± 1.05

− 1.3

5.28 ± 1.05

0.2

  

P = 0.425

 

P = 0.113

 

P = 0.828

 

Arterial hypertension

 No

1179 (44.5)

5.40 ± 1.22

REF

5.53 ± 0.76

REF

5.31 ± 0.95

REF

 Yes

1473 (55.5)

5.49 ± 1.17

1.8

5.41 ± 1.02

− 2.1

5.25 ± 1.06

− 1.1

  

P = 0.040

 

P = 0.001

 

P = 0.152

 

Hyperlipidaemia

 No

1416 (53.4)

5.46 ± 1.18

REF

5.51 ± 0.78

REF

5.30 ± 0.95

REF

 Yes

1236 (46.6)

5.44 ± 1.21

− 0.3

5.41 ± 1.05

− 1.9

5.25 ± 1.08

− 0.9

  

P = 0.758

 

P = 0.004

 

P = 0.222

 

Cardiovascular disease

 

 No

2483 (93.6)

5.46 ± 1.18

REF

5.49 ± 0.87

REF

5.30 ± 0.97

REF

 Yes

169 (6.4)

5.35 ± 1.39

− 2.0

5.16 ± 1.37

− 6.0

4.91 ± 1.44

− 7.4

  

P = 0.260

 

P < 0.001

 

P < 0.001

 

Chronic kidney disease

 

 No

2504 (94.4)

5.46 ± 1.18

REF

5.51 ± 0.82

REF

5.31 ± 0.96

REF

 Yes

148 (5.6)

5.35 ± 1.38

− 2.0

4.75 ± 1.75

− 13.7

4.73 ± 1.61

− 10.9

  

P = 0.279

 

P < 0.001

 

P < 0.001

 

Any systemic disease

 No

698 (26.3)

5.38 ± 1.27

REF

5.54 ± 0.72

REF

5.31 ± 0.94

REF

 Yes

1954 (73.7)

5.48 ± 1.17

1.7

5.44 ± 0.97

− 1.9

5.26 ± 1.04

− 0.8

  

P = 0.079

 

P = 0.009

 

P = 0.342

 

Eye conditions

 None

2226 (83.9)

5.49 ± 1.11

REF

5.50 ± 0.83

REF

5.30 ± 0.96

REF

 Non-VTDR

81 (3.1)

5.55 ± 1.06

1.1

5.26 ± 1.37

− 4.5

5.24 ± 1.23

− 1.2

 VTDR

24 (0.9)

4.40 ± 2.81

− 20.0

4.84 ± 1.77

− 12.1

4.58 ± 1.85

− 13.6

 Early AMD

151 (5.7)

5.35 ± 1.55

− 2.6

5.33 ± 1.15

− 3.1

5.18 ± 1.18

− 2.3

 Late AMD

7 (0.3)

4.92 ± 1.88

− 10.5

4.55 ± 1.58

− 17.3

5.07 ± 1.37

− 4.3

 Early glaucoma

31 (1.2)

5.12 ± 1.61

− 6.9

5.25 ± 1.38

− 4.5

5.25 ± 1.31

− 1.0

 Late glaucoma

26 (1.0)

5.25 ± 1.49

− 4.5

5.20 ± 1.43

− 5.6

5.16 ± 1.33

− 2.7

 Early MMD

99 (3.7)

5.02 ± 1.34

− 8.6

5.39 ± 1.04

− 2.1

5.08 ± 1.19

− 4.3

 Late MMD

7 (0.3)

5.37 ± 1.08

− 2.3

4.93 ± 1.41

− 10.5

4.78 ± 0.80

− 9.8

  

P < 0.001

 

P < 0.001

 

P = 0.009

 

Presenting VI (better eye)

 

 No

2558 (96.5)

5.47 ± 1.16

REF

5.48 ± 0.87

REF

5.30 ± 0.97

REF

 Yes

94 (3.5)

5.05 ± 1.85

− 7.6

4.94 ± 1.67

− 10.0

4.60 ± 1.68

− 13.3

  

P = 0.001

 

P < 0.001

 

P < 0.001

 

Presenting VI (worse eye)

 No

2149 (81.0)

5.52 ± 1.10

REF

5.53 ± 0.79

REF

5.36 ± 0.90

REF

 Yes

503 (19.0)

5.18 ± 1.52

− 6.1

5.19 ± 1.29

− 6.1

4.94 ± 1.35

− 7.8

  

P < 0.001

 

P < 0.001

 

P < 0.001

 
  1. Systemic diseases include: diabetes mellitus, arterial hypertension, hyperlipidaemia, cardio vascular disease and chronic kidney disease.
  2. Significant values are in [bold].
  3. BMI body mass index, VTDR vision-threatening diabetic retinopathy, AMD age related macular degeneration, MMD myopic macular degeneration, VI visual impairment, REF reference.